Neo Ivy Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Credo Technology Group
CRDO
|
+$4.92M |
| 2 |
Bruker
BRKR
|
+$4.83M |
| 3 |
Cognizant
CTSH
|
+$4.75M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$4.55M |
| 5 |
Travel + Leisure Co
TNL
|
+$4.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dolby
DLB
|
+$7.58M |
| 2 |
Welltower
WELL
|
+$7.56M |
| 3 |
Roivant Sciences
ROIV
|
+$7.12M |
| 4 |
TTM Technologies
TTMI
|
+$6.96M |
| 5 |
Warby Parker
WRBY
|
+$6.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.02% |
| 2 | Healthcare | 15.27% |
| 3 | Consumer Discretionary | 12.84% |
| 4 | Industrials | 11.71% |
| 5 | Financials | 9.99% |
Similar funds
Neo Ivy Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Neo Ivy Capital Management held 527 positions worth $379M, down 40% from $633M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Neo Ivy Capital Management withdrew a net $238M in Q1 2026, closing 212 positions and reducing 79 holdings. Its most notable exit was Dolby, an estimated $7.58M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Neo Ivy Capital Management opened a new position in Credo Technology Group worth $3.79M.
- Neo Ivy Capital Management's largest Q1 2026 buy was Credo Technology Group: 40,398 shares worth $3.79M.
- Neo Ivy Capital Management added most to Gartner in Q1 2026, an estimated $2.71M increase.
- Neo Ivy Capital Management's biggest Q1 2026 reduction was Roivant Sciences, cutting an estimated $7.12M.
- Neo Ivy Capital Management fully exited Dolby in Q1 2026, selling an estimated $7.58M.
- Neo Ivy Capital Management's ten largest holdings make up 11% of its $379M portfolio in Q1 2026.
- Neo Ivy Capital Management opened 191 new positions and closed 212 in Q1 2026.
- Neo Ivy Capital Management's portfolio value fell 40% quarter-over-quarter to $379M.
Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.